COVID-19 Updates: 36,401 New Cases, Vaccine For Kids In Sept, R-Value Drops Below 1 In India

India has recorded 36,500 fresh cases of the coronavirus on Wednesday. This is a rise from 35,134 reported the previous day but significantly below last Wednesday¡¯s count of 41,649.

India Has Administered More Than 56.57 Cr COVID-19 Vaccine Doses

India has administered more than 56.57 crore COVID-19 vaccine doses, the Union Health Ministry said on Wednesday.Over 48 lakh (48,81,588) doses have been administered on Wednesday as per the 7 pm provisional report.

REUTERS

The ministry said 25,93,571 vaccine doses were administered as the first dose and 5,77,183 doses as second dose in the age group 18-44 years on Wednesday.

COVID R-Value Drops To Below 1 In The Country, Including Kerala And NE

After breaching the value of 1 in the first week of August, the R number, which reflects how rapidly the coronavirus pandemic is spreading, has been steadily ebbing, according to researchers at the Institute of Mathematical Sciences, Chennai.

BCCL

¡°India's R has fallen to around 0.9,¡± Sitbara Sinha, who is leading the research, told PTI, citing their data.

21,427 New COVID-19 Cases, 179 More Deaths In Kerala

Kerala on Wednesday logged 21,427 new COVID-19 cases pushing the infection count to 37,25,005, as the number of people succumbing to the disease rose to 19,049 with 179 additional deaths.

BCCL

As many as 18,731 people have been cured of the infection since Tuesday, taking the total recoveries to 35,48,196 and the number of active cases to 1,77,683, a state government release said.

Discharges Outnumber New Covid Cases In Karnataka

Karnataka logged 1,365 new Covid cases against 1,558 discharges, while 22 fresh deaths were reported in the last 24 hours, a statement said on Wednesday

BCCL

The positivity rate for the day stood at 0.76 per cent and the case fatality rate at 1.61 per cent. The total active cases stood at 21,266, according to the state Health Department bulletin.

Covid Vaccine For Kids Likely In September Or Soon After

Presently, phase II and III trials of Covaxin are going on for children between 2-18 years. Hopefully, the results will be available soon. They will be presented to the regulators.

BCCL

So, by September or just after it, we may have Covid-19 vaccines for children. This apart, Zydus Cadila¡¯s vaccine trial is also going on for children.